Approaches for clinical pharmacists to implement pharmaceutical care for bronchiectasis patients

Abstract

Abstract: AIM: To explore a method for the pharmaceutical care for bronchiectasis patients. METHODS: To summarize the methods and experiences of pharmaceutical care through carrying out the pharmaceutical care for bronchiectasis patients by clinical pharmacists.RESULTS: According to bronchiectasis patient's morbid state,medication features and other factors,clinical pharmacists implemented individualized pharmaceutical care and finally got satisfactory therapeutic efficacy. CONCLUSION: Pharmaceutical care for bronchiectasis patients by clinical pharmacists could apparently improve drug use more safely,effectively and economically.

Key words: pharmaceutical care, bronchiectasis, clinical pharmacist

CLC Number:

R562.2

LIN Qi, DAI Wen-sen, GUO Li-jing. Approaches for clinical pharmacists to implement pharmaceutical care for bronchiectasis patients[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1238-1240.

References 10

[1]	成人支气管扩张症诊治专家共识编写组.成人支气管扩张症诊治专家共识(2012版)[J/CD].中华危重症医学杂志:电子版,2012,5(5):315-328.
[2]	赵语,聂绩.临床药师为临床提供药学服务的途径和方法[J].中国药房,2009,20(19):1519-1520.
[3]	骆松梅,叶伟红,华俊彦.临床药师参与慢性阻塞性肺病急性加重期患者治疗的实践[J].中国临床药理学与治疗学,2013,18(9):1014-1018.
[4]	Claxton K,Sculpher M,Drummond M.A rational framework for decision making by the National Institute for Clinical Excellece(NICE)[J].The Lancet,2002,360(9334):711-715.
[5]	Magely RB,Robert M.Establishing a pharmaceutical care databased[J].J Am Plarm Assoc,1996,36(1):60-62.
[6]	林勇. 吸入激素在支气管扩张症中的应用[J].中国呼吸与危重监护杂志,2007,6(3):168-170.
[7]	戴文森,林琦,林群英,等.沙美特罗氟替卡松吸入剂在成人支气管哮喘患者中使用情况的调查分析[J].中国药房,2012,23(44):4149-4151.
[8]	万志辉,范慧,胡克,等.长期吸入沙美特罗/氟替卡松联合小剂量红霉素口服治疗支气管扩张症的疗效观察[J].中国呼吸与危重监护杂志,2012,11(4):371-374.
[9]	Angrill J,Agust C,de Celis R,et al.Bacterial colonisation in patients with bronchiectasis:microbiological pattern and risk factors[J].Thorax,2002,57(1):15-19.
[10]	宋秀杰,路聪哲,方庭正,等.老年支气管扩张合并急性感染的病原菌及其耐药性研究[J].中国临床药理学与治疗学,2012,17(8):914-918.

[1]	LIU Xiumei, GUO Qianqian, FANG Yuan, CHEN Nan, QI Qi. Pharmaceutical care of patients with antithrombotic therapy after transjugular intrahepatic portal shunt [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 556-560.
[2]	ZHANG Zhaowei, LI Zuojun, HUANG Jian, LI Shuangqing, HE YiLin. Exploring the outbreak point for clinical pharmacists to provide pharmaceutical care in nephrology department [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 184-188.
[3]	YU Yahong, SONG Yu. Pharmacotherapy of patients with left ventricular assist devices [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 198-204.
[4]	ZHOU Haihui, ZHANG Haixia, GE Weihong. Analysis of the role of clinical pharmacist in the establishment of standardized cancer pain management ward [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1038-1042.
[5]	YANG Rui, LIU Hui, CHEN Zeheng, QI Tingting，ZHANG Zanling, QU Qiang. Clinical pharmacists use CYP2C19 genotyping test to guide individual medication therapy of Clopidogrel and to evaluate the efficacy of treatment [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 938-943.
[6]	YANG Bo, SHI Dawei, ZHENG Zaoqian. Pharmaceutical care on one case of hypobrinogenemia induced by hemocoagulase [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 932-936.
[7]	YUAN Yumei, WANG Ronghua, YANG Shuixin. Pharmaceutical service in statinsinduced Rhabdomyolysis by clinical pharmacists [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 704-708.
[8]	LI Jingjing, YU Yanxia, TANG Lian, ZHANG Jinkun, YU Qiang, SHANG Erning. Influence of clinical pharmaceutical care on medication compliance and treatment effect in Helicobacter pylori positive peptic ulcer outpatients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 199-204.
[9]	ZHU Xuting, HANG Yongfu. Clinical pharmacists' pharmaceutical care and practice in the department of nephrology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1174-1178.
[10]	LI Nan，HUANG Haitao，YONG Xiaolan. Pharmaceutical care for a patient misdiagnosed as Staphylococcus intermedius pulmonary infection [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(9): 1067-1071.
[11]	DANG Xiangji, ZHOU Lin, WANG Yixuan, ZENG Lu. Individualized antithrombotic therapy on one patient with chronic renal insufficiency [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 477-480.
[12]	YU Yang, HE Jiake, XIONG Aizhen, DING Nan. Role of clinical pharmacists in the anti-infective therapy after anterior cruciate ligament reconstructions: an individualized medicine perspective [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 194-197.
[13]	ZHANG Wen, WANG Lin, XU Wen-ke. Effects of examining prescriptions on rational application of antibiotics in diabetes patients combined with urinary tract infection [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 420-424.
[14]	WANG Lin, XU Wen-ke, ZHANG Wen, YANG Xiao-jun, WANG Wei-ping. Retrospective analysis of 90 cases of drug counseling online [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 162-166.
[15]	LIU Jun, XU Hang. Evaluation of warfarin anticoagulant management by clinic pharmacists on patients with cardiac valve surgery [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1021-1024.